Lack of IFN-γ-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines

International Journal of Cancer

Volumn 97, Issue 4, 2002, Pages 501-507

  Van Der Stoep, Nienke ^a   Biesta, Paula ^a   Quinten, Edwin ^a   Van Den Elsen, Peter J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antigen presentation; Class II transactivator; Developmental tumors; Major histocompatibility complex; Promoter methylation

Indexed keywords

AZACITIDINE; COMPLEMENTARY DNA; GAMMA INTERFERON; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RNA;

ANTIGEN EXPRESSION; ARTICLE; CHORIOCARCINOMA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NEUROBLASTOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TERATOCARCINOMA; TRANSACTIVATION; TUMOR CELL CULTURE;

AZACITIDINE; BURKITT LYMPHOMA; CARCINOMA; CELL DIFFERENTIATION; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, MHC CLASS II; GENES, REPORTER; HLA-DR ANTIGENS; HUMANS; INTERFERON TYPE II; MELANOMA; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036466853     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1623     Document Type: Article

References (55)

1. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)
2. Molecular analysis of G1B and G3A IFN-γ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction
3. Class II transactivator regulates the expression of multiple genes involved in antigen presentation
4. The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes
5. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA)
6. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency
7. Site α is crucial for two routes of IFN-γ MHC class I transactivation: The ISRE-mediated route and a novel pathway involving CIITA
8. The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and β2-microglobulin genes
9. Induction of MHC class I expression by the MHC class II transactivator CIITA
10. Role of MHC gene products in immune regulation
11. CD4+ T cells: Specificity and function
12. Regulation of the major histocompatibility complex-II genes: X,Y and other letters of the alphabet
13. Sequences and factors: A guide to MHC class-II transcription
14. Transfection of major histocompatibility complex class I and class II genes causes tumour rejection
15. Rejection of mouse sarcoma cells after transfection of MHC class II genes
16. Enhanced H-2 expression and T-cell-dependent rejection after intracerebral transplantation of the murine lymphoma YAC-1
17. Lymphocytic infiltration in juvenile thyroid carcinoma
18. An evaluation of the prognostic significance of HLA-DR expression in axillary-node-negative breast cancer
19. Prognostic factors of resectable intrahepatic cholangiocarcinoma
20. Absence of HLA class I and class II antigens as well as beta 2-microglobulin from normal and pathological human spermatozoa
21. Lack of expression of HLA class I and class II molecules on the human oocyte
22. Lack of HLA class I and class II antigens on human preimplantation embryos
23. Class 1 major histocompatibility complex antigens on human extra-villous trophoblast
24. The role of surface HLA-A,B,C molecules in tumour immunity
25. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
26. The HLA crossroad in tumor immunology
27. Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene
28. Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methylation of the IFN-inducible promoter (PIV) of CIITA
29. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5
30. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex
31. Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter
32. Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein
33. Assembly of functional regulatory complexes on MHC class II promoters in vivo
34. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA
35. Activation of the MHC class II transactivator CIITA by interferon-γ requires cooperative interaction between Statl and USF-1
36. Two distinct γ interferoninducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor β
37. Identification of distinct regions of 5′ flanking DNA that mediate constitutive, IFN-γ, STAT1, and TGF-β-regulated expression of the class II transactivator gene
38. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes
39. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA
40. Induction of class II major histocompatibility complex antigens in murine placenta by 5-azacytidine and interferon-gamma involves different cell populations
41. Transcription analysis of class II human leukocyte antigen genes from normal and immunodeficient B lymphocytes, using the polymerase chain reaction
42. High-efficiency transformation of mammalian cells by plasmid DNA
43. Simplified mammalian DNA isolation procedure
44. Major histocompatibility complex class I genes in murine fibrosarcoma IC9 are down regulated at the level of the chromatin structure
45. Beta 2-microglobulin expression in human embryonal neuroblastoma reflects its developmental regulation
46. Lack of class II transacti vator causes severe deficiency of HLA-DR expression in small cell lung cancer
47. Methylation of class II transactivator promoter IV: A novel mechanism of MHC class II gene control
48. Selection for beta 2-microglobulin mutation in mismatch repair-defective colorectal carcinomas
49. Tumor escape from immune recognition: Lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen
50. Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis
51. HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: Histopathologically similar but biologically distinct entities
52. Origin and roles of genomic methylation patterns in male germ cells
53. The establishment and maintenance of DNA methylation patterns in mouse somatic cells
54. DNA methylation: Past, present and future directions
55. Analysis of HLA antigens on germ cells in human semen